PreveCeutical develops proprietary method for extracting cannabinoids for Sol-gel

Share on facebook
Share on twitter
Share on linkedin
Share on email

PreveCeutical Medical INC. (CSE:PREV) CEO and President Stephen Van Deventer joined Steve Darling in the Vancouver studio of Proactive Investors to talk about the companies recent news that they had successfully optimized the conditions for extracting cannabinoids from one of its cannabis strains and developed a proprietary method for the accurate measurement of cannabinoids.

Van Deventer also shared details of their duel gene therapy program that deals with diabetes and obesity.

View original source video by clicking here

On Key

Related Posts

Wiśnia Bakajoko SKLEP ONLINE ZAMÓW NAJNOWSZĄ PŁYTĘ: Produkcja teledysku: Videoflow Media Zdjęcia/montaż: Sebastian Graboś Ujęcia lotnicze: Dawid Branecki ( Bit: Czaha Mix/mastering: Łukasz Stachyra View original source video by clicking here